PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2051997
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2051997
The global life science instrumentation market is projected to reach USD 92.53 billion by 2031 from USD 63.40 billion in 2025, at a CAGR of 6.5% from 2025 to 2031.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2025-2031 |
| Base Year | 2025 |
| Forecast Period | 2025-2031 |
| Units Considered | Value (USD billion) |
| Segments | Technology, Application, End User, and Region |
| Regions covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Factors such as increased funding and grants supporting research and development, rising proteomics research, and the increasing prevalence of life-threatening diseases are driving the growth of this market.

"The spectroscopy segment held the largest share of the market in 2025."
Based on technology, the life science instrumentation market is segmented into spectroscopy, chromatography, PCR, immunoassays, lyophilization, liquid handling systems, clinical chemistry analyzers, microscopy, flow cytometry, NGS, centrifuges, electrophoresis, cell counting, and other technologies. The spectroscopy segment held the largest market share in 2025. The spectroscopy market is driven by the growing need for advanced analytical solutions across pharmaceutical and biotechnology research, clinical diagnostics, and omics-based studies. The increasing focus on precision medicine, biomarker discovery, and drug development is also accelerating the use of spectroscopic techniques, such as UV-Vis, IR, NMR, and mass spectrometry, for accurate molecular analysis.
"The research applications segment accounted for the largest share of the market in 2025."
Based on application, the life science instrumentation market is segmented into research applications, clinical & diagnostic applications, and other applications. The research applications segment accounted for the largest market share in 2025. The research applications segment of the life science instrumentation market is primarily driven by the rapid growth of research-focused applications, driven by the increasing emphasis on understanding complex biological systems, molecular mechanisms, and disease pathways. Expanding investments in genomics, proteomics, and cell biology by academic institutions, government bodies, and private organizations are significantly boosting demand for advanced analytical and imaging technologies. Additionally, the growing focus on personalized medicine, drug discovery, and biomarker identification is accelerating the adoption of sophisticated instruments, such as mass spectrometry, chromatography, PCR, and next-generation sequencing, positioning the research segment as a major driver of market expansion over the coming years.
"The market in the Asia Pacific region is expected to witness the highest growth during the forecast period."
The Asia Pacific region is witnessing significant growth in the life science instrumentation market, driven by increasing government funding for biotechnology and pharmaceutical research, expanding academic and clinical research infrastructure, and the rapid growth of the healthcare and diagnostics sectors. Rising investments by global and regional players to establish manufacturing and R&D facilities in countries such as China, India, Japan, and South Korea are fueling technology adoption. The growing prevalence of chronic diseases, coupled with increasing demand for advanced diagnostic tools and precision medicine, is further boosting instrument utilization. Additionally, the emergence of contract research organizations (CROs), favorable regulatory reforms, and growing awareness of quality standards are enhancing market expansion.
The prominent players in the life science instrumentation market are Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Waters Corporation (US), Shimadzu Corporation (Japan), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), and Hitachi High-Technologies Corporation (Japan), among others.
Research Coverage
This report analyzes the life science instrumentation market by technology, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets by growth trends and forecasts market segment revenue across five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will help market leaders/new entrants with information on the closest approximations of revenue for the overall life science instrumentation market and its subsegments. This report will help stakeholders understand the competitive landscape and gain deeper insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides insights into key drivers, restraints, challenges, and opportunities.